We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+17.83%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$287M
Cap. Flow
+$147M
Cap. Flow %
13.65%
Top 10 Hldgs %
88.93%
Holding
27
New
7
Increased
6
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
LBRDK icon
Liberty Broadband Class C
LBRDK
+$105M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$43.8M
3
WLY icon
John Wiley & Sons Class A
WLY
+$30.3M
4
SOLV icon
Solventum
SOLV
+$21.8M
5
EDR
Endeavor Group Holdings, Inc.
EDR
+$20.1M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$62.2M
2
GMED icon
Globus Medical
GMED
+$19.7M
3
QDEL icon
QuidelOrtho
QDEL
+$18.8M
4
ATMU icon
Atmus Filtration Technologies
ATMU
+$12M
5
ZIMV
ZimVie
ZIMV
+$4.83M

Sector Composition

Rank Sector Weight
1 Healthcare 43.51%
2 Communication Services 30.19%
3 Industrials 21.18%
4 Financials 3.05%
5 Energy 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOLV icon
1
Solventum
SOLV
$13.5B
$197M 18.28%
2,827,672
+362,738
+15% +$21.8M
GHC icon
2
Graham Holdings Company
GHC
$4.97B
$193M 17.93%
235,271
+1,787
+0.8% +$1.36M
LBRDK icon
3
Liberty Broadband Class C
LBRDK
$4.15B
$131M 12.16%
+1,696,584
New +$105M
WLY icon
4
John Wiley & Sons Class A
WLY
$2.52B
$111M 10.25%
2,290,206
+659,689
+40% +$30.3M
GMED icon
5
Globus Medical
GMED
$10.4B
$81.3M 7.54%
1,137,050
-279,118
-20% -$19.7M
TBPH icon
6
Theravance Biopharma
TBPH
$874M
$76.7M 7.11%
9,511,150
+999,800
+12% +$8.66M
STGW icon
7
Stagwell
STGW
$1.84B
$50.2M 4.65%
7,147,662
– –
QDEL icon
8
QuidelOrtho
QDEL
$1.09B
$47.1M 4.37%
1,033,382
-463,766
-31% -$18.8M
INDV icon
9
Indivior Pharmaceuticals
INDV
$4.79B
$38.6M 3.58%
3,960,772
+3,737,340
+1,673% +$43.8M
NNI icon
10
Nelnet
NNI
$4.79B
$32.9M 3.05%
290,213
– –
DCO icon
11
Ducommun
DCO
$2.68B
$23.9M 2.22%
363,729
-18,766
-5% -$1.17M
EDR
12
DELISTED
Endeavor Group Holdings, Inc.
EDR
$20.9M 1.93%
+730,260
New +$20.1M
INVX
13
Innovex International
INVX
$1.87B
$15M 1.39%
+1,024,467
New +$16.4M
TSVT
14
DELISTED
2seventy bio
TSVT
$12.1M 1.12%
2,563,222
– –
NWSA icon
15
News Corp Class A
NWSA
$14.5B
$11.4M 1.06%
428,040
– –
AMTM
16
Amentum Holdings
AMTM
$5.51B
$11.1M 1.03%
+383,218
New +$10.9M
RVNC
17
DELISTED
Revance Therapeutics, Inc.
RVNC
$7.02M 0.65%
+1,353,321
New +$6.73M
FSP
18
Franklin Street Properties
FSP
$44.8M
$5.83M 0.54%
3,291,443
– –
OVID icon
19
Ovid Therapeutics
OVID
$435M
$4.86M 0.45%
4,116,773
+34,673
+0.8% +$36.2K
MODV
20
DELISTED
ModivCare
MODV
$3.73M 0.35%
+261,511
New +$6M
NWS icon
21
News Corp Class B
NWS
$16.4B
$1.47M 0.14%
52,534
– –
CEE
22
Central and Eastern Europe Fund
CEE
$135M
$851K 0.08%
79,400
-257,646
-76% -$2.72M
SN icon
23
SharkNinja
SN
$21B
$669K 0.06%
6,152
-715,426
-99% -$62.2M
TALK icon
24
Talkspace
TALK
$873M
$538K 0.05%
+257,238
New +$502K
ZIMV
25
DELISTED
ZimVie
ZIMV
$28.1K ﹤0.01%
1,771
-269,156
-99% -$4.83M
1
2

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
EPM
Elm Partners Management Philadelphia, Pennsylvania $2.31B AUM 16.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Madison Avenue Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Madison Avenue Partners held 27 positions worth $1.08B, up 36% from $792M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Madison Avenue Partners deployed $147M of net new capital in Q3 2024, opening 7 new positions and adding to 6 existing holdings. Its largest new stake was Liberty Broadband Class C: 1,696,584 shares worth $131M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was SharkNinja, an estimated $62.2M trimmed.

  • Madison Avenue Partners's largest Q3 2024 buy was Liberty Broadband Class C: 1,696,584 shares worth $131M.
  • Madison Avenue Partners added most to Indivior Pharmaceuticals in Q3 2024, an estimated $43.8M increase.
  • Madison Avenue Partners's biggest Q3 2024 reduction was SharkNinja, cutting an estimated $62.2M.
  • Madison Avenue Partners fully exited Atmus Filtration Technologies in Q3 2024, selling an estimated $12M.
  • Madison Avenue Partners's ten largest holdings make up 89% of its $1.08B portfolio in Q3 2024.
  • Madison Avenue Partners opened 7 new positions and closed 2 in Q3 2024.
  • Madison Avenue Partners's portfolio value rose 36% quarter-over-quarter to $1.08B.

Based on Madison Avenue Partners's 13F filing for Q3 2024, filed 14 Nov 2024.